Crescita Therapeutics Inc (CTX) - Total Liabilities

Latest as of December 2025: CA$4.75 Million CAD ≈ $3.44 Million USD

Based on the latest financial reports, Crescita Therapeutics Inc (CTX) has total liabilities worth CA$4.75 Million CAD (≈ $3.44 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Crescita Therapeutics Inc generate cash to assess how effectively this company generates cash.

Crescita Therapeutics Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Crescita Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Check CTX asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Crescita Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Crescita Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Zoom2u Technologies Ltd AU:Z2U	Australia	AU$5.91 Million
Checkin.com Group AB ST:CHECK	Sweden	Skr13.54 Million
Highfield Resources Ltd F:23H	Germany	€75.79 Million
SolGold PLC LSE:SOLG	UK	GBX305.94 Million
Metallis Resources Inc. V:MTS	Canada	CA$335.99K
Scandinavian ChemoTech AB Series B ST:CMOTEC-B	Sweden	Skr11.18 Million
The Motor & General Finance Limited NSE:MOTOGENFIN	India	Rs968.44 Million
Palash Securities Limited NSE:PALASHSECU	India	Rs1.02 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Crescita Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Crescita Therapeutics Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Crescita Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Crescita Therapeutics Inc (2014–2025)

The table below shows the annual total liabilities of Crescita Therapeutics Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$4.75 Million ≈ $3.44 Million	-20.09%
2024-12-31	CA$5.95 Million ≈ $4.30 Million	+2.96%
2023-12-31	CA$5.78 Million ≈ $4.18 Million	-21.82%
2022-12-31	CA$7.39 Million ≈ $5.34 Million	-12.02%
2021-12-31	CA$8.40 Million ≈ $6.07 Million	+47.37%
2020-12-31	CA$5.70 Million ≈ $4.12 Million	-0.54%
2019-12-31	CA$5.73 Million ≈ $4.14 Million	-33.06%
2018-12-31	CA$8.56 Million ≈ $6.19 Million	-9.52%
2017-12-31	CA$9.46 Million ≈ $6.84 Million	-41.65%
2016-12-31	CA$16.21 Million ≈ $11.73 Million	+255.95%
2015-12-31	CA$4.55 Million ≈ $3.29 Million	+21.86%
2014-12-31	CA$3.74 Million ≈ $2.70 Million	--

About Crescita Therapeutics Inc

TO:CTX Canada Drug Manufacturers - Specialty & Generic

Market Cap

$10.23 Million

CA$14.15 Million CAD

Market Cap Rank

#26834 Global

#1136 in Canada

Share Price

CA$0.76

Change (1 day)

+1.33%

52-Week Range

CA$0.42 - CA$0.76

All Time High

CA$1.82